-
Product Insights
NewLikelihood of Approval Analysis for Musculoskeletal Inflammation
Overview How likely is it that the drugs in Musculoskeletal Inflammation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Musculoskeletal Inflammation Overview Musculoskeletal inflammation refers to the body's response to irritation,...
-
Product Insights
NewLikelihood of Approval Analysis for Bone Metastasis
Overview How likely is it that the drugs in Bone Metastasis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bone Metastasis Overview Bone metastasis occurs when cancer cells spread from their...
-
Product Insights
NewLikelihood of Approval Analysis for Arthritis Pain
Overview How likely is it that the drugs in Arthritis Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arthritis Pain Overview Arthritis pain stems from inflammation in joints, causing discomfort,...
-
Product Insights
NewLikelihood of Approval Analysis for Bipolar I Disorder
Overview How likely is it that the drugs in Bipolar I Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bipolar I Disorder Overview Bipolar I Disorder is a mental health...
-
Product Insights
NewLikelihood of Approval Analysis for Developmental Disorders
Overview How likely is it that the drugs in Developmental Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Developmental Disorders Overview Developmental disorders comprise a spectrum of conditions affecting physical,...
-
Product Insights
NewLikelihood of Approval Analysis for Disruptive Behavior Disorder
Overview How likely is it that the drugs in Disruptive Behavior Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Disruptive Behavior Disorder Overview Disruptive Behavior Disorders (DBD) encompass conditions like...
-
Product Insights
NewLikelihood of Approval Analysis for Polyneuropathies
Overview How likely is it that the drugs in Polyneuropathies will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polyneuropathies Overview Polyneuropathies represent a group of disorders characterized by damage or dysfunction...
-
Product Insights
NewLikelihood of Approval Analysis for Post-Operative Pain
Overview How likely is it that the drugs in Post-Operative Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post-Operative Pain Overview Post-operative pain is a common consequence following surgical procedures,...
-
Product Insights
NewLikelihood of Approval Analysis for Somatic Pain
Overview How likely is it that the drugs in Somatic Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Somatic Pain Overview Somatic pain refers to a type of pain that...
-
Product Insights
NewLikelihood of Approval Analysis for Traumatic Pain
Overview How likely is it that the drugs in Traumatic Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Traumatic Pain Overview Traumatic pain arises from physical injuries or trauma to...